Probiotics in COVID-19 pandemic: when evidence lacks, rationale can still ease the way

Minerva Gastroenterol (Torino). 2023 Jun;69(2):314-317. doi: 10.23736/S2724-5985.20.02760-9. Epub 2020 Sep 4.

Authors

Cristiano Pagnini¹, Maria Carla DI Paolo², Lucia D'Alba², Riccardo Urgesi², Lorella Pallotta², Giuseppe Villotti², Giancarlo D'Ambra³, Gianfranco Delle Fave³, Maria Giovanna Graziani²

Affiliations

¹ Department of Gastroenterology and Digestive Endoscopy, S. Giovanni Addolorata Hospital, Rome, Italy - [email protected].
² Department of Gastroenterology and Digestive Endoscopy, S. Giovanni Addolorata Hospital, Rome, Italy.
³ Sapienza University, Rome, Italy.

PMID: 32883053
DOI: 10.23736/S2724-5985.20.02760-9

No abstract available

MeSH terms

COVID-19*
Humans
Pandemics
Probiotics* / therapeutic use
SARS-CoV-2